Billion-dollar acquisition of Sobi fails
Private equity funds Advent and Aurora failed to achieve the needed support by investors in Sobi before the final and decisive deadline and will therefore not be acquiring the pharmaceutical firm.
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen
They came very close, but stumbled before the finish line.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
